Equity
AOCI
Amgen AOCI increased by 26.4% to -$190M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.7%, from -$231M to -$190M. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a -23.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase indicates positive market valuation changes or favorable currency movements, while a decrease suggests unrealized losses or unfavorable currency impacts.
Detailed definition
Accumulated other comprehensive income represents the cumulative net change in equity resulting from items not included...
Peer comparison
Standard across all public companies reporting under GAAP, though the specific composition varies based on hedging strategies and international exposure.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$868M | -$808M | -$796M | -$763M | -$672M | -$652M | -$231M | -$268M | -$280M | -$126M | -$289M | -$190M | -$155M | -$336M | -$66M | -$231M | -$544M | -$422M | -$258M | -$190M |
| QoQ Change | — | +6.9% | +1.5% | +4.1% | +11.9% | +3.0% | +64.6% | -16.0% | -4.5% | +55.0% | -129.4% | +34.3% | +18.4% | -116.8% | +80.4% | -250.0% | -135.5% | +22.4% | +38.9% | +26.4% |
| YoY Change | — | — | — | — | +22.6% | +19.3% | +71.0% | +64.9% | +58.3% | +80.7% | -25.1% | +29.1% | +44.6% | -166.7% | +77.2% | -21.6% | -251.0% | -25.6% | -290.9% | +17.7% |
Range-$868M – -$66M
CAGR-27.4%
Avg YoY Growth-18.5%
Median YoY Growth+20.9%
Current Streak3 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is Amgen's aoci?
- Amgen (AMGN) reported aoci of -$190M in Q1 2026.
- How has Amgen's aoci changed year-over-year?
- Amgen's aoci increased by 17.7% year-over-year, from -$231M to -$190M.
- What is the long-term trend for Amgen's aoci?
- Over 5 years (2020 to 2025), Amgen's aoci has grown at a -23.5% compound annual growth rate (CAGR), from -$985M to -$258M.
- What does aoci mean?
- The cumulative total of unrealized gains and losses that bypass the income statement and go directly to equity.